Microarray Market Size to Hit USD 14.86 Bn By 2035

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. DataSources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Microarray Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Microarray Market

5.1. Covid-19: Microarray Industry Impact
5.2. Microarray Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Microarray Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Microarray Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Microarray Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Growing incidence of cancer worldwide
6.1.1.2. Increasing expenditure on research and development in the healthcare sector
6.1.2. Market Restraints
6.1.2.1. Stringent Regulations
6.1.3. Market Opportunities
6.1.3.1. Growing awareness regarding personalized medicines
6.1.3.2. Increasing preference for DNA based microarrays

Chapter 7. Global Microarray Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Microarray Market Revenue by Market Players
7.1.1.2. MicroarrayMarket Revenue Market Share by Market Players
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Microarray Market, By Product

8.1. Microarray Market, by Product
8.1.1. Consumables
8.1.1.1. Market Revenue and Forecast
8.1.2. Software & Services
8.1.2.1. Market Revenue and Forecast
8.1.3. Instruments
8.1.3.1. Market Revenue and Forecast

Chapter 9. Global Microarray Market, By Type

9.1. Microarray Market, by Type
9.1.1. DNA Microarrays
9.1.1.1. Market Revenue and Forecast
9.1.2. Protein Microarrays
9.1.2.1. Market Revenue and Forecast
9.1.3. Other Microarrays
9.1.3.1. Market Revenue and Forecast

Chapter 10. Global Microarray Market, By Application

10.1. Microarray Market, by Application
10.1.1. Agriculture
10.1.1.1. Market Revenue and Forecast
10.1.2. Research Applications
10.1.2.1. Market Revenue and Forecast
10.1.3. Drug Discovery
10.1.3.1. Market Revenue and Forecast
10.1.4. Diseases Diagnostics
10.1.4.1. Market Revenue and Forecast
10.1.5. Other Applications
10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Microarray Market, By End User

11.1. Microarray Market, by End User
11.1.1. Research & Academic Institutes
11.1.1.1. Market Revenue and Forecast
11.1.2. Pharmaceutical & Biotechnology Companies
11.1.2.1. Market Revenue and Forecast
11.1.3. Diagnostic Laboratories
11.1.3.1. Market Revenue and Forecast
11.1.4. Other End Users
11.1.4.1. Market Revenue and Forecast

Chapter 12. Global Microarray Market, Regional Estimates and Trend Forecast

12.1. North America
12.1.1. Market Revenue Forecast by Product
12.1.2. Market Revenue Forecast by Type
12.1.3. Market Revenue Forecast by Application
12.1.4. Market Revenue Forecast by End User
12.1.5. U.S
12.1.5.1. Market Revenue Forecast
12.1.6. Canada
12.1.6.1. Market Revenue Forecast
12.2. Europe
12.2.1. Market Revenue Forecast by Product
12.2.2. Market Revenue Forecast by Type
12.2.3. Market Revenue Forecast by Application
12.2.4. Market Revenue Forecast by End User
12.2.5. UK
12.2.5.1. Market Revenue Forecast
12.2.6. Germany
12.2.6.1. Market Revenue Forecast
12.2.7. France
12.2.7.1. Market Revenue Forecast
12.2.8. Rest of EU
12.2.8.1. Market Revenue Forecast
12.3. Asia Pacific (APAC)
12.3.1. Market Revenue Forecast by Product
12.3.2. Market Revenue Forecast by Type
12.3.3. Market Revenue Forecast by Application
12.3.4. Market Revenue Forecast by End User
12.3.5. China
12.3.5.1. Market Revenue Forecast
12.3.6. India
12.3.6.1. Market Revenue Forecast
12.3.7. Japan
12.3.7.1. Market Revenue Forecast
12.3.8. Rest of APAC
12.3.8.1. Market Revenue Forecast
12.4. LATAM
12.4.1. Market Revenue Forecast by Product
12.4.2. Market Revenue Forecast by Type
12.4.3. Market Revenue Forecast by Application
12.4.4. Market Revenue Forecast by End User
12.4.5. Brazil
12.4.5.1. Market Revenue Forecast
12.4.6. Rest of LATAM
12.4.6.1. Market Revenue Forecast
12.5. Middle East and Africa (MEA)
12.5.1. Market Revenue Forecast by Product
12.5.2. Market Revenue Forecast by Type
12.5.3. Market Revenue Forecast by Application
12.5.4. Market Revenue Forecast by End User
12.5.5. GCC
12.5.5.1. Market Revenue Forecast
12.5.6. North Africa
12.5.6.1. Market Revenue Forecast
12.5.7. South Africa
12.5.7.1. Market Revenue Forecast
12.5.8. Rest of MEA
12.5.8.1. Market Revenue Forecast

Chapter 13. Company Profiles

13.1. Illumina, Inc.
13.1.1. Company Overview, Business Information, Regional Presence
13.1.2. Product Portfolio Analysis
13.1.2.1. Product Details, Specification, Application
13.1.3. Revenue, Price, and Gross Margin
13.1.4. Recent Developments and Strategies
13.2. Agilent Technologies, Inc.
13.2.1. Company Overview, Business Information, Regional Presence
13.2.2. Product Portfolio Analysis
13.2.2.1. Product Details, Specification, Application
13.2.3. Revenue, Price, and Gross Margin
13.2.4. Recent Developments and Strategies
13.3. Thermo Fisher Scientific, Inc.
13.3.1. Company Overview, Business Information, Regional Presence
13.3.2. Product Portfolio Analysis
13.3.2.1. Product Details, Specification, Application
13.3.3. Revenue, Price, and Gross Margin
13.3.4. Recent Developments and Strategies
13.4. Merck & Co., Inc.
13.4.1. Company Overview, Business Information, Regional Presence
13.4.2. Product Portfolio Analysis
13.4.2.1. Product Details, Specification, Application
13.4.3. Revenue, Price, and Gross Margin
13.4.4. Recent Developments and Strategies
13.5. PerkinElmer, Inc.
13.5.1. Company Overview, Business Information, Regional Presence
13.5.2. Product Portfolio Analysis
13.5.2.1. Product Details, Specification, Application
13.5.3. Revenue, Price, and Gross Margin
13.5.4. Recent Developments and Strategies
13.6. Arrayit Corporation
13.6.1. Company Overview, Business Information, Regional Presence
13.6.2. Product Portfolio Analysis
13.6.2.1. Product Details, Specification, Application
13.6.3. Revenue, Price, and Gross Margin
13.6.4. Recent Developments and Strategies
13.7. Bio-Rad Laboratories
13.7.1. Company Overview, Business Information, Regional Presence
13.7.2. Product Portfolio Analysis
13.7.2.1. Product Details, Specification, Application
13.7.3. Revenue, Price, and Gross Margin
13.7.4. Recent Developments and Strategies
13.8. GE Healthcare
13.8.1. Company Overview, Business Information, Regional Presence
13.8.2. Product Portfolio Analysis
13.8.2.1. Product Details, Specification, Application
13.8.3. Revenue, Price, and Gross Margin
13.8.4. Recent Developments and Strategies
13.9. Molecular Devices, LLC
13.9.1. Company Overview, Business Information, Regional Presence
13.9.2. Product Portfolio Analysis
13.9.2.1. Product Details, Specification, Application
13.9.3. Revenue, Price, and Gross Margin
13.9.4. Recent Developments and Strategies
13.10. Affymetrix
13.10.1. Company Overview, Business Information, Regional Presence
13.10.2. Product Portfolio Analysis
13.10.2.1. Product Details, Specification, Application
13.10.3. Revenue, Price, and Gross Margin
13.10.4. Recent Developments and Strategies

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The microarray market size was valued at USD 6.47 billion in 2025 and expected to surpass USD 14.86 billion by 2035.

Answer : The microarray market is anticipated to grow at a compound annual growth rate of 8.67% from forecast period 2026 to 2035.

Answer : Factors such as growing incidence of cancer worldwide, increasing expenditure on research and development in the healthcare sector, growing number of applications of microarrays, advances in the fields of proteomics and genomics, developments in bioinformatics, evolution of softwareâ€™s, growing awareness regarding personalized medicines, and increasing preference for DNA based microarrays are driving the growth of microarray market.

Answer : In 2025, the North American region dominated the worldwide market with a market share of higher than 38%.

Answer : The key companies functioning in the worldwide microarray market are Illumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Merck & Co., Inc., PerkinElmer, Inc., Arrayit Corporation, Bio-Rad Laboratories, GE Healthcare, Molecular Devices, LLC, and Affymetrix among others.